2023-05-26 05:45:11
26.05.2023
Until now, there is no cure for Parkinson’s disease, but the causes of this degenerative disease have recently been discovered. This new discovery would help to reduce and control this disease.
Official statistics indicate that more than six million people worldwide suffer from Parkinson’s disease. This degenerative disease leads to the continuous loss of nerve cells in the brain without effective treatment. However, a recent study gave hope to confront the possible causes of this disease.
The study, the results of which were published in the “Lancet Neurology” magazine, under the supervision of American neurologist Andrew Sideroff, confirmed that the accumulation of the “alpha-synuclein” protein in the brain is indeed linked.Certain forms of Parkinson’s diseaseThis may open the way for early diagnosis of this disease.
The study concluded that the presence of elevated levels of this protein in the cerebrospinal fluid “helps with great accuracy (in determining) the typical forms of Parkinson’s disease.”
This new study, the first of its kind conducted on hundreds of patients, confirmed that monitoring the presence of alpha-synuclein protein at high levels can largely reflect a person’s Parkinson’s disease.
Results that will change the equation of diagnosis and clinical trials
However, the results are not equal in accuracy. Patients who carry a gene mutation known as LRRK2, which is associated with certain forms of Parkinson’s disease, do not have these lumps systematically. It is not currently possible to perform a “biological” test for Parkinson’s disease It is not currently diagnosed except through its apparent symptoms.
Nevertheless, this study “lays the foundations for a biological diagnosis of Parkinson’s disease,” according to a comment also published in The Lancet Neurology by neurologists Daniela Berg and Christine Klein, who were not involved in the research.
And the two doctors considered that the results of the study prove that alpha-synuclein protein “changes the equation in diagnosis, research and clinical trials for Parkinson’s disease.”
They also pointed out that what is particularly interesting is that the researchers also detected a high concentration of this protein in patients who had early signs of the disease. Parkinson’sespecially the impaired sense of smell, without proof.
Parkinson’s, along with Alzheimer’s, is one of the major diseases affecting the brain. The patient with Parkinson’s gradually loses the ability to move.
H.D / A.H
1685220645
#discovery #Parkinsons #open #hope #treatment